
    
      OBJECTIVES:

        -  Determine the maximum tolerated dose (MTD) of liposomal vincristine given with
           dexamethasone in patients with relapsed or refractory acute lymphoblastic leukemia
           (ALL).

        -  Determine the efficacy of liposomal vincristine given with dexamethasone in these
           patients.
    
  